Navigation Links
Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
Date:8/21/2008

py, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at http://www.telik.com.

This press release contains "forward-looking" statements, including statements regarding the potential qualities and capabilities of the lead compounds described above, including the potential ability of the lead compounds to prevent or stop tumor cell division and starve tumors, and the potential development of a drug candidate to treat cancer. These forward-looking statements are based upon Telik's current expectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the quarter ended June 30, 2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA, and TRAP are trademarks or registered trademarks of Telik, Inc.


'/>"/>
SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
2. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
3. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
4. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
5. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
6. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
7. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
8. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
9. Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR
10. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
11. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Bed bugs compromised Penn State. ... confirmed it. Meanwhile, My Cleaning Products offered complimentary samples of ... the pests without using harmful chemical elements. , Based ... the affected building was actually a dormitory , My ... made on May 13 and bed bug presence was confirmed ...
(Date:5/23/2013)... NH (PRWEB) May 23, 2013 Ralph Huber, ... of their emergency management products and emergency survival kits ... , This announcement was made at the quarterly executive board ... with a moment of silence for the Oklahoma tornado victims ... that the quality of their emergency kits is paramount. ...
(Date:5/22/2013)... Mechanicsburg, PA (PRWEB) May 22, 2013 ... Controller with the integrated potentiometers or via a ... compact design measuring two and one half inches square ... from a zero voltage switched, low noise solid state ... line power isolation for the communication port and sensor ...
(Date:5/22/2013)... 2013 iLuv Creative Technology, the premier ... the mobile lifestyle, announces they are now shipping MultiCharger-X, ... multiple iPad devices efficiently. Winner of the 2013 internationally ... Design award, MultiCharger-X is revolutionizing the way businesses, schools, ... deployed. , MultiCharger-X (iAD910) combines the ...
Breaking Biology Technology:Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits 2New AC Temperature Controller Announced by Oven Industries 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3
... Fincor (Pink Sheets: FINC) through a share ... leading company in the field of water technologies, enlarges its ... Fincor also acquired the WETTECH and Advanced Cavitation Technologies. ... several natural drugs to fight Malaria and Dengue fever and ...
... Tigris Pharmaceuticals, Inc., a privately held drug development ... Phase I clinical trial of GGTI-2418. GGTI-2418 is ... that induces apoptosis by downregulating several pivotal oncogenic and ... Dr. Peter O,Dwyer, Professor of Medicine at the ...
... and Student Research, Partnering with Industry , ... ... University of Massachusetts Boston today officially opened a cutting-edge ... university,s research and development activity and provide entrepreneurial opportunities for ...
Cached Biology Technology:Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 3UMass Boston Opens Venture Development Center to Expand R&D Activity 2UMass Boston Opens Venture Development Center to Expand R&D Activity 3UMass Boston Opens Venture Development Center to Expand R&D Activity 4
(Date:5/22/2013)... together in a major new effort to educate the ... Earth,s people with clean water that looms ahead in ... article in the current edition of Chemical & ... Chemical Society (ACS), the world,s largest scientific society. , ... Jerald L. Schnoor, Ph.D., explain that shortages of reliable ...
(Date:5/22/2013)... responsible for legionellosis, an infectious disease that can lead ... has developed a complex method enabling it to camouflage ... these acting against the infectious bacteria. , Research led ... which teams from the National Institute of Health (NIH) ... Barcelona (BSC) have also participated, has described for the ...
(Date:5/21/2013)... long time that some creatures evolve more quickly than ... But it may be that height plays a role, ... U. S. National Evolutionary Synthesis Center. , In ... journal Nature Communications , Lanfear and colleagues report ... a database of global patterns in plant height for ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2
... has waged a successful guerrilla war against the human immune ... Journal of Biological Chemistry has exposed one of the ... may aid in future drug development. , Malaria parasites (plasmodia) ... human hosts the parasites first set up shop in liver ...
... the world,s plant species rely on animals to transfer their ... pollinators is the bee, made up of about 30,000 species ... than half of the world,s flowering plants. In recent years, ... the U.S. and Europe has placed the health of ecosystems ...
... last decade, childhood obesity has grown into an epidemic, ... recommendations that pediatricians check toddlers for elevated cholesterol. ... intervene. A study presented at a pediatric research ... as early as age two, when children reach a ...
Cached Biology News:Research exposes new target for malaria drugs 2Saving our bees 2Saving our bees 32 years old -- a childhood obesity tipping point? 2
... Antigen Afinity Purified Tyrosine Hydroxylase ... antibody was raised against synthetic ... residues surrounding the phospho-Ser40 of ... antibody was purified by sequential ...
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
Biotin anti-human CD164...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Biology Products: